Clinical Trial

Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)

Study acronym: First Line
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 31, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
To generate real-world evidence from the parent study, REAL AF registry, on the use of Thermocool SmartTouch SF (STSF) catheter in ablation for the treatment of paroxysmal atrial fibrillation (PAF).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-22.
Trial Details
NCT Number NCT07092774
Lead Sponsor Heart Rhythm Clinical and Research Solutions, LLC
Collaborators: Biosense Webster, Inc.
Conditions Paroxysmal Atrial Fibrillation (PAF)
Enrollment 344 participants
Start Date 2024-04-01
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-31